Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP by Product, Application & End-users The global ophthalmic devices market will witness a robust CAGR of 4.7%, valued at $54.96 billion in 2021, and expected to appreciate and reach $83.09 billion by 2030, confirms Strategic Market Research. North America represented a sizable industry share of 43% in 2021. Ophthalmology is a field of medicine that studies structure, function, and various eye disorders. It is a practice that focuses on the wellness of the eyes. The anatomy, physiology, and disorders that can impact the eye are covered. Ophthalmology has traditionally covered all elements of visual function, both in health and ailment. In ophthalmology, animal eyes are included since visual function, and optic disorders are comparable in humans and animals. Ophthalmologists are medical practitioners who specialize in preventing, diagnosing, and treating eye diseases. Refraction, orthoptics, binocular vision, and strabismus are all aspects of visual function that an ophthalmologist may investigate during a medical examination to determine a diagnosis. The 74th World Health Assembly, held from 24th May to 1st June 2021, established two new global eye care targets for 2030: a 40% rise in effective coverage of refractive defects and a 30% increase in effective coverage of cataract operations. An ophthalmic medical device serves a medical purpose and is used in optometry and ophthalmology. These devices range from non-invasive diagnostic equipment and instruments to invasive devices like contact lenses and implantable devices like intraocular lenses and glaucoma stents. These devices include surgical equipment and systems, such as lasers and phacoemulsification machines. The influence of the incidence of eye illness, demographic shifts, technical breakthroughs in ophthalmology, and the rising elderly population are some of the reasons driving the growth of the ophthalmology industry. Key Market Drivers - Rising Incidence of Ocular Ailments, Government Initiatives, and Increasing Emphasis on Educating People The market's major growth is attributed to the rising incidence of ocular ailments such as cataracts, diabetic retinopathy, myopia, etc. The International Diabetes Federation (IDF) estimated that 463 million people worldwide had diabetes mellitus (DM) in 2019, and the count will reach 700 million by 2045. CDC (Centers for Disease Control & Prevention) announced that diabetic retinopathy affects 93 million people worldwide, and in the United States, it will increase to 14.6 million by 2050, making it a key driver soon. Moreover, several government organizations are also attempting to raise awareness about ocular disorders, which would help to cushion the industry expansion throughout the anticipated time. Increased emphasis on consumer education and training among eye care providers and understanding eye illnesses and associated problems will help drive the ophthalmic devices market expansion. For example, on 27th November 2021, Network18 Group and Novartis India launched the “Netra Suraksha – India against Diabetes” campaign. This program aims to create and raise awareness about diabetes-related eye disease hazards and encourage diabetic individuals to have their eyes tested routinely to avoid blindness. Prevent Blindness is a national non-profit organization that promotes awareness and education about inflammatory eye disease and outlines initiatives that should be taken to save sight. Prevent Blindness has named 27th September – 3rd October 2021 the first-ever Inflammatory Eye Disease Awareness Week to educate the netizens about the various kinds of IEDs. IED can be detected and treated early, which can help to prevent eyesight loss. Restraints - Poor Accessibility to Eye Care Products, Lack of Awareness and Health Insurance, And Cost of Equipment Higher costs of equipment and technology, lack of awareness and poor accessibility to quality eye care products, and lack of health insurance in emerging countries are hindering the growth of this industry. Opportunities - The Rise in The Population of Older People and The Increasing Rate of Adaption of New Technologies Developing nations worldwide, including Mexico, China, Russia, India, Brazil, and South Africa, provide future development possibilities for ophthalmic device makers due to their large population bases. As asserted by the UN Economic and Social Affairs Report of 2019, Asia's population of individuals over 65 is predicted to grow from 395.3 Mn in 2019 to 587.4 Mn by 2030, increasing the incidence of age-related eye illnesses in the area. In China, glaucoma in people over 45 years is roughly 3.5 %; however, it rises significantly with age and is predicted to be over 9 percent in the population over 65. Nerve transplant treatments, higher quality bioengineered Corneas, artificial Corneas, and retinal Implants (Bionic Eye, the Crispr Technology in genetic illnesses of the eye), detection of dry eye syndrome, macular degeneration, uveitis using a slit lamp, phacoemulsification systems, and many other diagnostics and treatment techniques like the usage of intraocular lenses, contact lenses along with lasers which are gaining popularity, may eventually stimulate the expansion of the ophthalmic devices industry. On the Glaucoma 360 New Horizons Forum, Ranya Habash, MD of the Refractive Surgery Alliance Society, indicated that wearable AR and VR goggles might be utilized for visual field and macular tests, refraction, and monitoring eye movements. In addition, AI-based therapies for glaucoma may be beneficial, and biosensors may help with continuous IOP monitoring. Ophthalmic Devices Market Analysis Of Different Segments Covered in the Report Based on Product Optical Coherence Tomography Scanners Site Lamps Fundus Camera Autorefractors and Keratometers Ophthalmic Ultrasound Imaging System Ophthalmic A-Scan Ultrasound Ophthalmic B-Scan Ultrasound Ophthalmic Ultrasound Biomicroscope Ophthalmic Pachymeters Phoropters Perimeters/Visual Field Analyzers Tonometers Wavefront aberrometers Lensometers Ophthalmoscopes Optical Biometry Systems Specular Microscopes Retinoscopes Corneal Topography Systems Based on Application Glaucoma Vitreo retinal disorders Cataract Refractor Disorders Based on End-User Hospitals and Eye Clinics Academic and Research Laboratory Others Regional Coverage Analysis North America The US. Canada Europe The UK. Germany France Russia Italy Netherlands Switzerland Sweden Poland Ireland Asia Pacific India China Japan Indonesia Thailand South Korea Australia Malaysia Singapore Philippines Latin America Brazil Mexico Argentina The Middle East and Africa South Africa Saudi Arabia Turkey Iran UAE Israel Product Analysis & Insights The optical coherence tomography (OCT) category spearheaded and dominated the market, accounting for more than 20% of total revenue in the year 2021, and is destined to grow at a promising CAGR of 5.4 % over the projected period. OCT generates high-resolution cross-sectional and three-dimensional pictures of biological microstructure and is used to diagnose glaucoma, associated macular degeneration, and diabetic eye. According to a study by National Glaucoma Research, glaucoma affected over 80 million individuals worldwide in 2020, & this number will rise to over 111 million by 2040. The most common kind of glaucoma, open-angle, affects more than three million Americans, with 2.7 million over 40. Over the forecast period, the ophthalmoscopes sector is expected to increase by 5.3 %. Ophthalmoscopes diagnose papilledema, glaucoma, CMV retinitis, AMD, and diabetic retinopathy. Application Analysis & Insights The cataract sector led the ophthalmic devices market, accounting for 41.6 % of revenue in 2021, and is predicted to rise significantly throughout the forecast period due to the widespread use of ophthalmic equipment for cataract surgery. Cataracts are the major cause of blindness, as stated by World Health Organization (WHO). Cataracts are responsible for over half of all incidents of blindness worldwide. According to one ARVO journal, in 2020, approximately 15.2 million people aged 50 and more were blind, with another 78.8 million with moderate to severe vision impairment (MSVI) owing to cataracts. Since 2000, there has been a 29.7% increase in cataract blindness and a 93.1 % increase in cases of MSVI. The refractor disorders sector is expected to increase quickly over the projected period. As asserted by WHO, around 2.2 billion people worldwide possess near or far-distance visual impairment. Ophthalmic instruments such as retinoscopes and phoropters are highly recommended for treating such disorders and correcting refractive faults. Hence, the ophthalmic viscosurgical devices industry is expected to grow at a CAGR of 7.9% throughout the forecast period. The surgical ophthalmic equipment market is projected to grow at a CAGR of 5.5 %. End-Users Analysis & Insights The hospitals and eye clinics segment dominated the ophthalmic devices market with a 76.9 % share and is likely to maintain its dominance during the forecast period. This might be linked to the increased use of ophthalmic technology in hospitals and the availability of low-cost, effective therapy in clinics. The rapid surge in the number of mergers and acquisitions among hospitals and ophthalmic clinics is expected to increase the overall demand of new installations in the future years. On 8th October 2021, the city-based Aditya Jyot Eye Hospital merged with Agarwals Eye Hospitals, which announced intentions to invest close to $ 38 million in Maharashtra over the next two years to expand its network. According to a release, the merger with Aditya Jyot, a three-decade-old facility, will bring Agarwals' overall network to 100 hospitals. According to the statement, it has previously declared intentions to invest more than $ 139 million over the next three years to build 100 new hospitals and 500 vision centers worldwide. Agarwals Group is currently active in 11 countries and over ten Indian states. Over 400 ophthalmologists and 4,000 personnel work in its facilities, which have treated over 12 million patients. The academic and research laboratories market is predicted to rise rapidly during the projected period. Academic and research laboratories fund ophthalmic care. Region Analysis & Insights North America represented a sizable market share of 43% in 2021. The rapidly expanding senior population and the increased frequency of chronic eye disorders like diabetic retinopathy caused by high stress and unhealthy lifestyles are seen as high-impact contributing drivers for the sector. According to Cleveland Clinic, almost 7% of children under 18 in the United States had been afflicted with an eye disease or condition. Nearly 3% of youth under 18 with vision problems are blind. Vision loss is one of the most frequent debilitating situations in children and is among the top ten reasons for impairment in individuals over 18. Also, glaucoma affects the American economy by $2.86 billion in direct costs and lost productivity each year. Furthermore, the adoption of new funding models for ophthalmologic therapy and a strong regulatory environment aiming at patient safety are projected to fuel the demand for ophthalmic equipment in this area. Because of rapidly developing healthcare infrastructure, increased incidence of eye illnesses such as glaucoma, and increasing patient awareness, the Asia Pacific market is expected to expand at the fastest CAGR of 5.7 % over the projected period. According to a recently published journal, Glaucoma patients in Asia were expected to increase by 16.0 % to 59.51 million in 2020 and by 57.6 % to 80.87 million in 2040. In the year 2040, South-Central Asia will overtake East Asia as the region with the highest number of netizens suffering from primary open-angle glaucoma (23.25 million) and secondary glaucoma (4.28 million) and overall glaucoma (32.90 million). Nonetheless, in 2040, East Asia will continue to have the highest number of people with primary angle-closure glaucoma (9.13 million). Ophthalmic Devices Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 54.96 billion The revenue forecast in 2030 USD 83.09 billion Growth rate CAGR of 4.7 % The base year for estimation 2020 Historical data 2017 – 2020 Unit USD Billion, CAGR (2020 - 2030) Segmentation By Application, By Type, By End Users, By Region. By Product Type Fundus Cameras, Perimeters/Visual Field Analyzers, Autorefractors and Keratometers, Optical Coherence Tomography scanners, Ophthalmic Pachymeters, Slit Lamps, Phoropters, Optical Biometry Systems, Ophthalmoscopes, Lensometers, Corneal Topography Systems, Specular Microscopes, Retinoscopes, Tonometers, Ultrasound Imaging Systems, Wavefront aberrometers. By Application Cataract, Vitreo retinal disorders, Glaucoma, Refractor Disorders By End-User Hospitals and Eye Clinics, Academic and Research Laboratory, Others By Region North America, Asia Pacific, Europe, Latin America, The Middle East & Africa Country Scope United States of America, United Kingdom, Italy, Germany, France, Spain, Canada, China, India, Japan, Brazil, Argentina, Mexico, South Africa, Saudi Arabia, etc. Company Usability Profiles Zeiss, Hoya Corporation, Johnson & Johnson Vision, Alcon Management S. A., Johnson & Johnson Vision, HOYA Corporation, Zeiss, Neo Vision Foundation, Lumenis Be Ltd., ClearLab, OPHTEC BV, ClearLab, HEINE Optotechnik GmbH & Co. KG, NIDEK Co.Ltd., Glaukos Corporation, Haag-Streit Group, Topcon,. STAAR Surgical, Ziemer Ophthalmic Systems, Canon India Pvt Ltd., Heidelberg Engineering GmbH, Oculentis. Ophthalmic Devices Market Competitive Landscape Analysis The competitive landscape analysis portrays an overview of some prominent players operating in the target market. Product innovation coupled with continued R&D operations to create sophisticated technologies has catalyzed the industry's growth. In the market, there are many key operational companies, and some of the active organizations in the industry are as follows: Zeiss Hoya Corporation Johnson & Johnson Vision Alcon Management S.A. EssilorLuxottica Neo Vision Foundation Lumenis Be Ltd. OPHTEC BV ClearLab HEINE Optotechnik GmbH & Co. KG NIDEK Co.Ltd. Glaukos Corporation Haag-Streit Group Topcon STAAR Surgical Ziemer Ophthalmic Systems Canon India Pvt Ltd. Heidelberg Engineering GmbH Oculentis Recent Developments: On May 2022, The National Institutes of Health awarded West Virginia University an $11 million grant, making it only the second university in the country to earn financing for a visual-sciences Center of Biomedical Research Excellence. The COBRE funding will assist WVU in developing novel approaches to prevent, treat, and reduce the growth of currently incurable vision diseases. According to a university news release, West Virginia has the second-highest rate of visual disability in the US. On January 2022, Alcon bought Ivantis, a firm that makes the Hydrus Microstent Glaucoma Surgery (MIGS) device, which is used to reduce ocular pressure in open-angle glaucoma patients during cataract surgery. Alcon's market presence has been strengthened as a result of this purchase. It also enabled Alcon to introduce the Hydrus Microstent in the international market and emphasize its evidence-based research. On July 2022, QHP Capital, a management company for NovaQuest Private Equity, announced the acquisition of Lexitas Pharma Services, an ophthalmology contract research organization that supports medical devices and biopharmaceutical clinical trials. The company delivers end-to-end support, solution, and expertise in developing posterior and anterior segments of ophthalmology. In October 2021, Retina Scan Duo 2 was launched by NIDEK Co Ltd., a combined fundus camera and OCT System. The system is well integrated with new and advanced features which are designed to increase clinical efficiency and screening, along with the user-friendly features that were subsumed from the previous model. In October 2021 US FDA granted 510K approval to iCare USA for its EIDON Ultra-Widefield Lens Module that has the capability of capturing 120-degree images of the retina in single-shot or images up to the level of 200 degrees in mosaic function mode. On May 2021, Essilor Stellest was approved by the FDA in the United States. It is a spectacle lens designed to cure myopia and halt its growth in youngsters. This strategic decision will assist the company in strengthening its product range and expanding into the ophthalmic devices industry. Various Devices Manufactured by Some of the Organizations: Name Feature Key Player OPMI LUMERA 700 Zeiss's premier ocular surgery microscope for Vitreo-Retinal and cataract surgery offers the most advanced ophthalmic technology. It was developed to integrate many visualization technologies and video imaging into a single platform. The OPMI Lumera 700 offers surgeons a smooth, integrated operating microscope with better surgical results. Zeiss GALILEI G4 ColorZ Aids in the achievement of peak performance in refractive and therapeutic eye care. It delivers accurate and exact data over the cornea, allowing consistent planning and good outcomes. Ziemer EVO+ Visian ICL With an Expanded Optic intended for patients with larger pupils, EVO+ continues the Evolution in Visual Freedom. EVO+ is the newest version of EVO lenses, constructed of Collamer and based on the renowned EVO architecture. STAAR Surgical Frequently Asked Question About This Report State the total market value of the market report? The total market value was $ 54.96 billion in 2021. The ophthalmic devices market trend is projected to reach $ 83.1 billion by 2030, and the ophthalmic devices market share will rise with this at a CAGR of 4.7 %. What is the ophthalmic devices market growth? The global ophthalmic devices market is expected to grow at a compound annual growth rate (CAGR) of 4.7% from 2021 to 2030 to reach USD 83.09 billion by 2030. What is the estimated valuation of the global market? The market is forecasted to reach $ 83.1 billion by 2030. How big is the ophthalmic devices market? The global ophthalmic devices market size was $54.96 bn in 2021 and is predicted to reach $83.09 bn by 2030, Representing a CAGR of 4.7%. How will surgical devices contribute to the market growth through 2027? The market is projected to grow at a CAGR of 5.5 %, and hence it will further boost the growth of the ophthalmic devices market. Sources https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/aditya-jyot-eye-hospital-to-merge-with-agarwals-eye-hospitals/articleshow/86869218.cms https://pib.gov.in/PressReleasePage.aspx?PRID=1693908 https://my.clevelandclinic.org/health/diseases/17130-eye-diseases https://www.glaucomapatients.org/basic/statistics/ https://iovs.arvojournals.org/article.aspx?articleid=2776048 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at Market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Ophthalmic Devices Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Ophthalmic Devices Market 4.2.1 Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Market, by region, 2021 - 2030 (USD Million) 4.4 By Product Business Analysis 4.4.1 Market, By Product, 2021 - 2030 (USD Million) 4.5 By End-User Business Analysis 4.5.1 Market, By End-User, 2021 - 2030 (USD Million) 4.6 Application Business Analysis 4.6.1 Market, By Application, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Application Analysis 5.11.1. Trends in Application (2014-2020) 5.11.2. Trends in Application (2021-2030) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By Region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Manufacturing Sites, Area Served, Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Optical Coherence Tomography Scanners 7.3.1. Optical Coherence Tomography Scanners, 2021 - 2030 (USD Million) 7.4. Site Lamps 7.4.1. Site Lamps Market, 2021 - 2030 (USD Million) 7.5. Fundus Camera 7.5.1. Fundus Camera Market, 2021 - 2030 (USD Million) 7.6. Autorefractors and Keratometers 7.6.1. Autorefractors and Keratometers Market, 2021 - 2030 (USD Million) 7.7. Ophthalmic Ultrasound Imaging System 7.7.1. Ophthalmic Ultrasound Imaging System Market, 2021 - 2030 (USD Million) 7.7.1.1 Ophthalmic A-Scan Ultrasound Market, 2021 - 2030 (USD Million) 7.7.1.2 Ophthalmic B-Scan Ultrasound Market, 2021 - 2030 (USD Million) 7.7.1.3 Ophthalmic Ultrasound Biomicroscope Market, 2021 - 2030 (USD Million) 7.8. Ophthalmic Pachymeters 7.8.1. Ophthalmic Pachymeters Market, 2021 - 2030 (USD Million) 7.9. Phoropters 7.9.1. Phoropters Market, 2021 - 2030 (USD Million) 7.10. Perimeters/Visual Field Analyzers 7.10.1. Perimeters/Visual Field Analyzers Market, 2021 - 2030 (USD Million) 7.11. Tonometers 7.11.1. Tonometers Market, 2021 - 2030 (USD Million) 7.12. Wavefront Aberrometers 7.12.1. Wavefront Aberrometers Market, 2021 - 2030 (USD Million) 7.13. Lensometers 7.13.1. Lensometers Market, 2021 - 2030 (USD Million) 7.14. Ophthalmoscopes 7.14.1. Ophthalmoscopes Market, 2021 - 2030 (USD Million) 7.15. Optical Biometry Systems 7.15.1. Optical Biometry Systems Market, 2021 - 2030 (USD Million) 7.16. Specular Microscopes 7.16.1. Specular Microscopes Market, 2021 - 2030 (USD Million) 7.17. Retinoscopes 7.17.1. Retinoscopes Market, 2021 - 2030 (USD Million) 7.18. Corneal Topography Systems 7.18.1. Corneal Topography Systems Market, 2021 - 2030 (USD Million) 8. Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Eye Clinics 8.3.1. Hospitals and Eye Clinics Market, 2021 - 2030 (USD Million) 8.4. Academic and Research Laboratory 8.4.1. Academic and Research Laboratory Market, 2021 - 2030 (USD Million) 8.5. Others 8.5.1. Others Market, 2021 - 2030 (USD Million) 9. Market: By Application Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Glaucoma 9.3.1. Glaucoma Market, 2021 - 2030 (USD Million) 9.4. Vitreo retinal disorders 9.4.1. Vitreo retinal disorders Market, 2021 - 2030 (USD Million) 9.5. Cataract 9.5.1. Cataract Market, 2021 - 2030 (USD Million) 9.6. Refractor Disorders 9.6.1. Refractor Disorders Market, 2021 - 2030 (USD Million) 10. Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 10.1.2. North America Market, By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, by Application, 2021 - 2030 (USD Million) 10.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, by Application, 2021 - 2030 (USD Million) 10.1.4.2. Canada 10.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, by Application, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, by Application, 2021 - 2030 (USD Million) 10.2.4. Europe Market, by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, by Application, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, by Application, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, by Application, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Application, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, by Application, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, by Application, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. India Market, by Application, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. Japan Market, By Product, 2021 - 2030 (USD Million) 10.3.4.3.2. Japan Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, by Application, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, by Application, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFIC Market, By Product, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFIC Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFIC Market, by Application, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, by Application, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, by Application, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, by Application, 2021 - 2030 (USD Million) 10.4.4.3. Rest of Latin America 10.4.4.3.1. Rest of the Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin America Market, by Application, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, by Application, 2021 - 2030 (USD Million) 10.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Zeiss. 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. Hoya Corporation 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. Johnson & Johnson Vision 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. Alcon Management S.A. 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. EssilorLuxottica 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Neo Vision Foundation 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Lumenis Be Ltd 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. OPHTEC BV 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. ClearLab. 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. HEINE Optotechnik GmbH & Co. KG 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development 11.11. NIDEK Co.Ltd 11.11.1. Company overview 11.11.2. Financial performance 11.11.3. Product Portfolio Analysis 11.11.4. Business Strategy & Recent Development 11.12. Glaukos Corporation 11.12.1. Company overview 11.12.2. Financial performance 11.12.3. Product Portfolio Analysis 11.12.4. Business Strategy & Recent Development 11.13. Haag-Streit Group 11.13.1. Company overview 11.13.2. Financial performance 11.13.3. Product Portfolio Analysis 11.13.4. Business Strategy & Recent Development 11.14. Topcon 11.14.1. Company overview 11.14.2. Financial performance 11.14.3. Product Portfolio Analysis 11.14.4. Business Strategy & Recent Development 11.15. STAAR Surgical 11.15.1. Company overview 11.15.2. Financial performance 11.15.3. Product Portfolio Analysis 11.15.4. Business Strategy & Recent Development 11.16. Ziemer Ophthalmic Systems 11.16.1. Company overview 11.16.2. Financial performance 11.16.3. Product Portfolio Analysis 11.16.4. Business Strategy & Recent Development 11.17. Canon India Pvt Ltd 11.17.1. Company overview 11.17.2. Financial performance 11.17.3. Product Portfolio Analysis 11.17.4. Business Strategy & Recent Development 11.18. Heidelberg Engineering GmbH 11.18.1. Company overview 11.18.2. Financial performance 11.18.3. Product Portfolio Analysis 11.18.4. Business Strategy & Recent Development 11.19. Oculentis 11.19.1. Company overview 11.19.2. Financial performance 11.19.3. Product Portfolio Analysis 11.19.4. Business Strategy & Recent Development List of Tables (81 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Optical Coherence Tomography Scanners, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Site Lamps, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR Fundus Camera, BY REGION, 2021-2030 (USD Million) TABLE 5. Market FOR Autorefractors and Keratometers, BY REGION, 2021-2030 (USD Million) TABLE 6. Market FOR Ophthalmic Ultrasound Imaging System, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Ophthalmic Pachymeters, BY REGION, 2021-2030 (USD Million) TABLE 8. Market FOR Phoropters, BY REGION, 2021-2030 (USD Million) TABLE 9. Market FOR Perimeters/Visual Field Analyzers, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Tonometers, BY REGION, 2021-2030 (USD Million) TABLE 11. Market FOR Wavefront Aberrometers, BY REGION, 2021-2030 (USD Million) TABLE 12. Market FOR Lensometers, BY REGION, 2021-2030 (USD Million) TABLE 13. Market FOR Ophthalmoscopes, BY REGION, 2021-2030 (USD Million) TABLE 14. Market FOR Optical Biometry Systems, BY REGION, 2021-2030 (USD Million) TABLE 15. Market FOR Specular Microscopes, BY REGION, 2021-2030 (USD Million) TABLE 16. Market FOR Retinoscopes, BY REGION, 2021-2030 (USD Million) TABLE 17. Market FOR Corneal Topography Systems, BY REGION, 2021-2030 (USD Million) TABLE 18. Market, By End-User, 2021-2030 (USD Million) TABLE 19. Market FOR Hospitals and Eye Clinics, BY REGION, 2021-2030 (USD Million) TABLE 20. Market FOR Academic and Research Laboratory, BY REGION, 2021-2030 (USD Million) TABLE 21. Market FOR Others, BY REGION, 2021-2030 (USD Million) TABLE 22. Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 23. Market FOR Glaucoma, BY REGION, 2021-2030 (USD Million) TABLE 24. Market FOR Vitreo retinal disorders, BY REGION, 2021-2030 (USD Million) TABLE 25. Market FOR Cataract, BY REGION, 2021-2030 (USD Million) TABLE 26. Market FOR Refractor Disorders, BY REGION, 2021-2030 (USD Million) TABLE 27. Market, BY REGION, 2021-2030 (USD Million) TABLE 28. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 29. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 30. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 31. NORTH AMERICA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 32. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 33. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 34. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 35. EUROPE Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 36. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 37. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 38. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 39. ASIA-PACIFIC Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 40. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 41. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 42. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 43. LAMEA Market, BY APPLICATION, 2021-2030 (USD Million) TABLE 44. Zeiss.: COMPANY SNAPSHOT TABLE 45. Zeiss.: OPERATING SEGMENTS TABLE 46. Hoya Corporation: COMPANY SNAPSHOT TABLE 47. Hoya Corporation: OPERATING SEGMENTS TABLE 48. Johnson & Johnson Vision: COMPANY SNAPSHOT TABLE 49. Johnson & Johnson Vision: OPERATING SEGMENTS TABLE 50. Alcon Management S.A.: COMPANY SNAPSHOT TABLE 51. Alcon Management S.A.: OPERATING SEGMENTS TABLE 52. EssilorLuxottica: COMPANY SNAPSHOT TABLE 53. EssilorLuxottica: OPERATING SEGMENTS TABLE 54. Neo Vision Foundation: COMPANY SNAPSHOT TABLE 55. Neo Vision Foundation: OPERATING SEGMENTS TABLE 56. Lumenis Be Ltd: COMPANY SNAPSHOT TABLE 57. Lumenis Be Ltd: OPERATING SEGMENTS TABLE 58. ClearLab: COMPANY SNAPSHOT TABLE 59. ClearLab: OPERATING SEGMENTS TABLE 60. HEINE Optotechnik GmbH & Co. KG.: COMPANY SNAPSHOT TABLE 61. HEINE Optotechnik GmbH & Co. KG.: OPERATING SEGMENTS TABLE 62. NIDEK Co.Ltd: COMPANY SNAPSHOT TABLE 63. NIDEK Co.Ltd: OPERATING SEGMENTS TABLE 64. Glaukos Corporation: COMPANY SNAPSHOT TABLE 65. Glaukos Corporation: OPERATING SEGMENTS TABLE 66. Haag-Streit Group: COMPANY SNAPSHOT TABLE 67. Haag-Streit Group: OPERATING SEGMENTS TABLE 68. Topcon: COMPANY SNAPSHOT TABLE 69. Topcon: OPERATING SEGMENTS TABLE 70. STAAR Surgical: COMPANY SNAPSHOT TABLE 71. STAAR Surgical: OPERATING SEGMENTS TABLE 72. Ziemer Ophthalmic Systems: COMPANY SNAPSHOT TABLE 73. Ziemer Ophthalmic Systems: OPERATING SEGMENTS TABLE 74. Canon India Pvt Ltd: COMPANY SNAPSHOT TABLE 75. Canon India Pvt Ltd: OPERATING SEGMENTS TABLE 76. Heidelberg Engineering GmbH: COMPANY SNAPSHOT TABLE 77. Heidelberg Engineering GmbH: OPERATING SEGMENTS TABLE 78. Oculentis: COMPANY SNAPSHOT TABLE 79. Oculentis: OPERATING SEGMENTS TABLE 80. OPHTEC BV: COMPANY SNAPSHOT TABLE 81. OPHTEC BV: OPERATING SEGMENTS List of Figures (22 Figures) Figure 1 Ophthalmic Devices Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Research Methodology: Hypothesis Building Figure 5 Market: Product-Based Estimation Figure 6 Top 20 Companies with Highest No. Of Patent in Last 9 Years Figure 7 No. Of Patents Granted Per Year, 2019–2020 Figure 8 Import Data for Ophthalmic Devices, By Country, 2016–2020 (USD Thousand) Figure 9 Export Data for Ophthalmic Devices, By Country, 2016–2020 (USD Thousand) Figure 10 Data Triangulation Methodology Figure 11 Market, By End-User, 2019 vs 2025 (USD Million) Figure 12 Market Share, By Application, 2019 vs 2025 (USD Million) Figure 13 Market Share, By Product, 2019 vs 2025 (USD Million) Figure 14 Geographical Snapshot of the Market Figure 15 Optical Coherence Tomography Scanners to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 16 Cataract to Witness Higher CAGR in Market for Application Segment during Forecast Period. Figure 17 Hospitals and Eye Clinics to Witness Higher CAGR in the Market for End-User Segment during Forecast Period. Figure 18 North America Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges Figure 20 North America: Market Snapshot Figure 21 Asia Pacific: Market Snapshot Figure 22 Vendor Dive: Evaluation Overview